Ladenburg Thalmann Financial Services’s RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 RXIIW Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio RXIIW Stock Details RXIIW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-3,000	Closed	-$1K	–	5512
2018 Q3	$1K	Hold	3,000	–	–	﹤0.01%	5105
2018 Q2	$1K	Hold	3,000	–	–	﹤0.01%	5064
2018 Q1	$1K	Sell	3,000 -27,000	-90%	-$17.6K	﹤0.01%	5064
2017 Q4	$4K	Hold	30,000	–	–	﹤0.01%	4639
2017 Q3	$5K	Hold	30,000	–	–	﹤0.01%	4439
2017 Q2	$5K	Hold	30,000	–	–	﹤0.01%	4361
2017 Q1	$7K	Hold	30,000	–	–	﹤0.01%	4201
2016 Q4	$6K	Buy	+30,000	New	+$5.4K	﹤0.01%	4181

Ladenburg Thalmann Financial Services's RXIIW Position: Q4 2018 in Review

Ladenburg Thalmann Financial Services sold out of RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 (RXIIW) in Q4 2018, closing a stake of 3,000 shares — an estimated $1K sold.

Ladenburg Thalmann Financial Services first reported a position in RXIIW in Q4 2016 and held it in 8 quarters. The position peaked at $7K in Q1 2017. 0 funds tracked by Wall St. Rank hold RXIIW as of Q4 2018.

Ladenburg Thalmann Financial Services reported no remaining RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 position as of Q4 2018 after selling out during the quarter.
Ladenburg Thalmann Financial Services sold 3,000 RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 shares in Q4 2018, an estimated $1K.
Ladenburg Thalmann Financial Services first reported a position in RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 in Q4 2016 and held it in 8 quarters.
Ladenburg Thalmann Financial Services's RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 position peaked at $7K in Q1 2017.
0 funds tracked by Wall St. Rank held RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 as of Q4 2018.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2018, filed 14 Feb 2019.